TXMD - TherapeuticsMD agrees to be acquired by EW Healthcare Partners

Women’s healthcare company TherapeuticsMD (NASDAQ:TXMD) announced on Tuesday that it reached an agreement to be acquired by an affiliate of private equity firm EW Healthcare Partners in an all-cash transaction for $10 per share. TherapeuticsMD (TXMD) shares have added ~346% in the pre-market on the news. Per the terms, EW Healthcare Partners is set to start a tender offer to acquire all outstanding shares of TXMD common stock at the agreed purchase price followed immediately by a merger. The buyout offer worth about $177M including debt represents a premium of 367.3% over the closing price of TherapeuticsMD (TXMD) shares on Friday. The transaction is expected to close on or before July 13, 2022 subject to certain conditions.

For further details see:

TherapeuticsMD agrees to be acquired by EW Healthcare Partners